Search Filters:

The items contained in the list are being used to filter the search results. Click them to remove them from the search filter.
Displaying 1 - 20 of 212
PIPS Search Results
PIP Number Active Substance Conditions / Indications Invented Name Therapeutic area Decision Type Compliance Check Compliance outcome Date Published Sort ascending
MHRA-101707-PIP01-24
  • AMG 193
  • Treatment of non-small cell lung cancer
  • Not available at present
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101729-PIP01-24
  • Ifinatamab deruxtecan
  • Treatment of prostate malignant neoplasms
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101730-PIP01-24
  • Ifinatamab deruxtecan
  • Treatment of oesophageal cancer
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101660-PIP01-24
  • RUXOLITINIB PHOSPHATE
  • Treatment of prurigo nodularis
  • OPZELURA
  • OPZELURA
  • OPZELURA
  • OPZELURA
  • Dermatology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101412-PIP01-24
  • Pridopidine hydrochloride
  • Treatment of amyotrophic lateral sclerosis (ALS)
  • Nurzigma
  • Neurology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101770-PIP01-24
  • SEMAGLUTIDE
  • Treatment of Chronic Kidney Disease
  • Ozempic
  • Ozempic
  • Ozempic
  • Ozempic
  • Ozempic
  • Uro-Nephrology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101694-PIP01-24
  • Human IgG1 monoclonal antibody targeting amyloid transthyretin
  • Treatment of transthyretin-mediated amyloidosis
  • Neurology
  • Cardiovascular Diseases
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101664-PIP01-24
  • SECUKINUMAB
  • Treatment of polymyalgia rheumatica
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Immunology -Rheumatology-Transplantation
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101654-PIP01-24
  • Volrustomig
  • Treatment of head and neck epithelial malignant neoplasms
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101605-PIP01-24
  • Telisotuzumab adizutecan
  • Treatment of lung carcinoma (small cell and non-small cell carcinoma)
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101702-PIP01-24
  • Modified messenger ribonucleic acid encoding individual patient-specific tumour neoantigens V940 (mRNA-4157)
  • Treatment of melanoma
  • Not available at present
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101457-PIP01-24
  • Acasunlimab
  • Treatment of lung cancer
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101746-PIP01-24
  • H-(D)p-Benzoylphenylalanyl-(D)seryl-(D)tryptophanyl-(D)seryl-(D)pentafluorophenylalanyl-(D)cyclohexylalanyl-(D)arginyl-(D)arginyl-(D)arginyl-(D)glutaminyl-(D)arginyl-(D)arginine acetate salt
  • Treatment of pancreatic cancer
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101411-PIP01-24
  • Erdafitinib
  • Treatment of urothelial carcinoma
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101680-PIP01-24
  • CICLOSPORIN
  • Treatment of dry eye disease (DED)
  • Vevizye
  • Vevizye
  • Vevye
  • Ophthamology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101677-PIP01-24
  • Rilvegostomig
  • Treatment of Lung Cancer Treatment of Biliary Tract Cancer
  • Rilvegostomig
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101690-PIP01-24
  • EMPAGLIFLOZIN
  • Derivative of 3‐phenyl‐3H,4H,6H,7H-pyrano[3,4‐d]imidazol‐4‐one (BI 690517)
  • Treatment of heart failure
  • Not available at present
  • Cardiovascular Diseases
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101546-PIP01-24
  • SECUKINUMAB
  • Treatment of vasculitides
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Cosentyx
  • Immunology -Rheumatology-Transplantation
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101243-PIP01-23
  • 3-[2-(Dimethylamino)ethyl]-1H-indol-4-yl dihydrogen phosphate
  • Major depressive disorder
  • Psychiatry
W: decision granting a waiver in all age groups for the listed condition(s). No
MHRA-101737-PIP01-24
  • GOZETOTIDE
  • Visualisation of prostate specific membrane antigen in prostate cancer
  • Isoprotrace
  • Isoprotrace 10 microgram, kit voor radiofarmaceutisch preparaat
  • Isoprotrace 10 Mikrogramm Kit für ein radioaktives Arzneimittel
  • Diagnostic
  • Oncology
W: decision granting a waiver in all age groups for the listed condition(s). No